0001493152-20-009917.txt : 20200527 0001493152-20-009917.hdr.sgml : 20200527 20200527161550 ACCESSION NUMBER: 0001493152-20-009917 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200527 DATE AS OF CHANGE: 20200527 EFFECTIVENESS DATE: 20200527 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VBI Vaccines Inc/BC CENTRAL INDEX KEY: 0000764195 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367784 FILM NUMBER: 20915404 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-830-3031 MAIL ADDRESS: STREET 1: 222 THIRD STREET STREET 2: SUITE 2241 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: SciVac Therapeutics Inc. DATE OF NAME CHANGE: 20150717 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD. DATE OF NAME CHANGE: 20100910 FORMER COMPANY: FORMER CONFORMED NAME: LEVON RESOURCES LTD DATE OF NAME CHANGE: 19850305 D 1 primary_doc.xml X0708 D LIVE 0000764195 VBI Vaccines Inc/BC 222 THIRD STREET SUITE 2241 CAMBRIDGE MA MASSACHUSETTS 02142 617-830-3031 BRITISH COLUMBIA, CANADA None SciVac Therapeutics Inc. LEVON RESOURCES LTD. LEVON RESOURCES LTD Corporation true Jeff Baxter 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director President and Chief Executive Officer, Director Steve Gillis 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Joanne Cordeiro 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Blaine McKee 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Michel De Wilde 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Christopher McNulty 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Director Chief Financial Officer and Head of Business Development, Director Damian Braga 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Director Nell Beattie 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Chief Business Officer Francisco Diaz-Mitoma 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Chief Medical Officer Avi Mazaltov 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Global Head of Manufacturing and SciVac General Manager David E. Anderson 222 Third Street Suite 2241 Cambridge MA MASSACHUSETTS 02142 Executive Officer Chief Scientific Officer Pharmaceuticals Decline to Disclose 06b false 2020-05-22 false true true true false 0 4700000 4700000 0 K2 HealthVentures, the lender in this transaction, may convert $4,000,000 of the above amount into common shares of the issuer, while the remaining $700,000 represents the value of warrant shares issued to lender in the same transaction. false 1 0 0 0 false VBI Vaccines Inc/BC /s/ Jeff Baxter Jeff Baxter Chief Executive Officer and Director 2020-05-27